Armand-Ugón M - Search Results

1

Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.

Blanco J, Barretina J, Gutiérrez A, Armand-Ugón M, Cabrera C, Clotet B, Esté JA. Blanco J, et al. AIDS Res Hum Retroviruses. 2002 Jan 1;18(1):27-38. doi: 10.1089/088922202753394691. AIDS Res Hum Retroviruses. 2002. PMID: 11804554

2

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.

Martínez MA, Gutiérrez A, Armand-Ugón M, Blanco J, Parera M, Gómez J, Clotet B, Esté JA. Martínez MA, et al. AIDS. 2002 Dec 6;16(18):2385-90. doi: 10.1097/00002030-200212060-00002. AIDS. 2002. PMID: 12461411

3

Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events.

Blanco J, Barretina J, Ferri KF, Jacotot E, Gutiérrez A, Armand-Ugón M, Cabrera C, Kroemer G, Clotet B, Esté JA. Blanco J, et al. Virology. 2003 Jan 20;305(2):318-29. doi: 10.1006/viro.2002.1764. Virology. 2003. PMID: 12573577 Free article.

4

Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death.

Barretina J, Blanco J, Armand-Ugón M, Gutiérrez A, Clotet B, Esté JA. Barretina J, et al. Antivir Ther. 2003 Apr;8(2):155-61. Antivir Ther. 2003. PMID: 12741628

5

Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.

Bosch B, Blanco J, Pauls E, Clotet-Codina I, Armand-Ugón M, Grigorov B, Muriaux D, Clotet B, Darlix JL, Esté JA. Bosch B, et al. Antimicrob Agents Chemother. 2005 Oct;49(10):4296-304. doi: 10.1128/AAC.49.10.4296-4304.2005. Antimicrob Agents Chemother. 2005. PMID: 16189111 Free PMC article.

6

HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.

Moncunill G, Armand-Ugón M, Pauls E, Clotet B, Esté JA. Moncunill G, et al. AIDS. 2008 Jan 2;22(1):23-31. doi: 10.1097/QAD.0b013e3282f303e6. AIDS. 2008. PMID: 18090388

7

Reduced fitness of HIV-1 resistant to CXCR4 antagonists.

Armand-Ugón M, Quiñones-Mateu ME, Gutiérez A, Barretina J, Blanco J, Schols D, De Clercq E, Clotet B, Esté JA. Armand-Ugón M, et al. Antivir Ther. 2003 Feb;8(1):1-8. Antivir Ther. 2003. PMID: 12713058

8

HIV-1 resistance to the gp41-dependent fusion inhibitor C-34.

Armand-Ugón M, Gutiérrez A, Clotet B, Esté JA. Armand-Ugón M, et al. Antiviral Res. 2003 Jul;59(2):137-42. doi: 10.1016/s0166-3542(03)00071-8. Antiviral Res. 2003. PMID: 12895697

9

The anti-HIV activity of ADS-J1 targets the HIV-1 gp120.

Armand-Ugón M, Clotet-Codina I, Tintori C, Manetti F, Clotet B, Botta M, Esté JA. Armand-Ugón M, et al. Virology. 2005 Dec 5;343(1):141-9. doi: 10.1016/j.virol.2005.08.007. Epub 2005 Sep 15. Virology. 2005. PMID: 16168454 Free article.

10

HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region.

Senserrich J, Pauls E, Armand-Ugón M, Clotet-Codina I, Moncunill G, Clotet B, Esté JA. Senserrich J, et al. Virology. 2008 Mar 15;372(2):421-9. doi: 10.1016/j.virol.2007.10.045. Epub 2007 Dec 18. Virology. 2008. PMID: 18068205 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters